Quantitative in vivo measurement of central benzodiazepine receptors in the brain of cats by use of positron-emission tomography and [11C] flumazenil

American Journal of Veterinary Research

Volumn 64, Issue 8, 2003, Pages 999-1002

  Shimada, Yuhei ^a,b,d   Kiyosawa, Motohiro ^c   Nariai, Tadashi ^c   Oda, Keiichi ^a   Toyama, Hinako ^a,e   Ono, Kenichirou ^b   Senda, Michio ^a,f   Ishiwata, Kiichi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d Sakuradai Animal Hospital   (Japan)

^e NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^f INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; BRAIN RECEPTOR; CARBON 11; FLUMAZENIL;

ANIMAL ANATOMY; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BRAIN; BRAIN CORTEX; BRAIN DISEASE; CAT; CEREBELLUM; CLINICAL OBSERVATION; CONTROLLED STUDY; CORPUS STRIATUM; DISTRIBUTION VOLUME; EXPERIMENTAL MODEL; IMAGE ANALYSIS; IN VIVO STUDY; MALE; MEASUREMENT; MESENCEPHALON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; THALAMUS; VETERINARY MEDICINE;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CARBON RADIOISOTOPES; CATS; FLUMAZENIL; GABA MODULATORS; MALE; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED;

ANIMALIA; FELIS CATUS;

EID: 0042121282     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.999     Document Type: Article

References (27)

1. Malizia AL, Nutt DJ. The effects of flumazenil in neuropsychiatric disorders. Clin Neuropharmacol 1995;18:215-232.
2. Duncan JS. Positron emission tomography receptor studies. Adv Neurol 1999;79:893-899.
3. Juhasz C, Chugani DC, Muzik O, et al. Relationship between EEG and positron emission tomography abnormalities in clinical epilepsy. J Clin Neurophysiol 2000;17:29-42.
4. Heiss WD. Imaging the ischemic penumbra and treatment effects by PET. Keio J Med 2001;50:249-256.
5. A receptor shows a ligand-gated receptor super-family. Nature 1987;328:221-227.
6. A receptor subunit for benzodiazepine pharmacology. Nature 1989;338:582-585.
7. A receptor. J Neurosci 1990;10:2330-2337.
8. Olsen RW. GABA-benzodiazepine-barbiturate receptor interactions. J Neurochem 1981;37:1-13.
9. Skolnick P, Rice KC, Barker JL, et al. Interaction of barbiturates with benzodiazepine receptors in the central nervous system. Brain Res 1982;233:143-156.
10. Farb DH, Borden LA, Chan CY, et al. Modulation of neuronal function through benzodiazepine receptors: biochemical and electrophysiological studies of neurons in primary monolayer cell culture. Ann N Y Acad Sci 1984;435:1-31.
11. Study RE, Barker JL. Diazepam and (-)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci U S A 1981;78:7180-7184.
12. Asano T, Ogasawara N. Chloride-dependent stimulation of GABA and benzodiazepine receptor binding by pentobarbital. Brain Res 1981;225:212-216.
13. Roy S, Pomier-Layrargues G, Butterworth RF, et al. Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors. Hepatology 1988;8:845-849.
14. Meyer HP, Legemate DA, van den Brom W, et al. Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil. Metab Brain Dis 1998;13:241-251.
15. Mohler H, Richards JG. Agonist and antagonist benzodiazepine receptor interaction in vitro. Nature 1981;294:763-765.
16. Shimada Y, Uemura K, Ardekani BA, et al. Application of PET-MRI registration techniques to cat brain imaging. J Neurosci Methods 2000;101:1-7.
17. Mintun MA, Raichele ME, Kilbourn MR, et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984;15:217-227.
18. 11C]flumazenil in human plasma: assessment as the standardized value for quantitative PET studies. Ann Nucl Med 1988;12:55-59.
19. Sakiyama Y, Sato A, Senda M, et al. Positron emission tomography reveals changes in global and regional cerebral blood flow during noxious stimulation of normal and inflamed elbow joints in anesthetized cats. Exp Brain Res 1998;118:439-446.
20. Watanabe M, Uchida H, Okada H, et al. A high resolution PET for animal studies. IEEE Trans Med imaging 1992;11:577-580.
21. Heiss WD, Graf R, Fujita T, et al. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats. Stroke 1997;28:2045-2051.
22. Schmid L, Bottlaender M, Brouillet E, et al. Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon. J Pharmacol Exp Ther 1996; 276:977-983.
23. Hayakawa N, Uemura K, Ishiwata K, et al. A PET-MRI registration technique for PET studies of the rat brain. Nucl Med Biol 2000; 27:121-125.
24. Luzzani F, Colombo G, Glasser A. Central benzodiazepine receptors in the spinal cord and other regions of the CNS of the cat. Neuropharmacology 1984;23:1137-1140.
25. Frey KA, Holthoff VA, Koeppe RA, et al. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol 1991;30:663-672.
26. A/benzodiazepine receptors: cellular and subcellular localization in the CNS with monoclonal antibodies. J Neurosci 1987;7:1866-1886.
27. Macdonald GA, Frey KA, Agranoff BW, et al. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology 1997;26:277-282.